C07J 33/00
Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with
Official title: Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
C07J33/00 (Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with) appears on 108 US grants and 46 published applications in this corpus.
Search patents in C07J- Granted patents
- 108
- Published applications
- 46
- Assignees
- 67
- Inventors
- 259
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 3 | 0 |
| 1979 | 4 | 0 |
| 1980 | 3 | 0 |
| 1981 | 6 | 0 |
| 1982 | 1 | 0 |
| 1983 | 3 | 0 |
| 1984 | 3 | 0 |
| 1985 | 6 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 3 | 0 |
| 1992 | 0 | 0 |
| 1993 | 5 | 0 |
| 1994 | 2 | 0 |
| 1995 | 7 | 0 |
| 1996 | 7 | 0 |
| 1997 | 4 | 0 |
| 1998 | 5 | 0 |
| 1999 | 3 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 2 |
| 2003 | 2 | 3 |
| 2004 | 1 | 2 |
| 2005 | 2 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 2 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 2 | 0 |
| 2011 | 0 | 1 |
| 2012 | 1 | 1 |
| 2013 | 1 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 2 |
| 2016 | 1 | 1 |
| 2017 | 1 | 4 |
| 2018 | 1 | 1 |
| 2019 | 3 | 4 |
| 2020 | 2 | 2 |
| 2021 | 3 | 7 |
| 2022 | 2 | 2 |
| 2023 | 1 | 3 |
| 2024 | 2 | 1 |
| 2025 | 2 | 3 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Bile acid-GCPII inhibitor conjugates to treat inflammatory diseases, including inflammatory bowel disease (IBD)4 Aug 2026US 12,698,306 B2Institute of Organic Chemistry and Biochemistry of the AS CR, V.V.I.
- Biofunctional thiophene monomers and polymers thereof for electronic biomedical devices18 Mar 2025US 12,252,582 B2University of Delaware
- Intermediates for the preparation of 11-methylene steroids18 Feb 2025US 12,227,537 B2Crystal Pharma, S.A.U.
- Process for the preparation of 3α-hydroxy-5α-pregnan-20-one (brexanolone)3 Sep 2024US 12,077,559 B2Industriale Chimica S.R.L.
- Compositions and methods for treating CNS disorders2 Apr 2024US 11,945,836 B2Sage Therapeutics, Inc.
- Organic Photoredox Catalysts, Compositions, and Conversion Processes24 Sep 2026US 2026/0284647 A1Colorado State University Research Foundation
- Compounds and methods for the treatment of dermal and ocular disorders26 Feb 2026US 2026/0055110 A1Azura Ophthalmics Ltd.
- Processes for synthesis of withanolides and withaferins and analogs thereof29 May 2025US 2025/0171493 A1H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Compositions and methods for treating cns disorders6 Feb 2025US 2025/0042934 A1Sage Therapeutics, Inc.
- Pharmaceutical composition having anti-cancer immunostimulating effect and/or immune checkpoint inhibition potentiating effect2 Jan 2025US 2025/0002526 A1Keio University
Most cited
By later US patents
- 4-Aza-17.beta.-substituted-5.alpha.-androstan-3-one-reductase inhibitors159US 4,377,584 AMerck & Co., Inc. · 1983
- 3,20-Dioxo-1,4-pregnadiene-17.alpha.-ol 17-aromatic heterocycle carboxylates112US 4,472,393 ASchering Corporation · 1984
- Soft steroids having anti-inflammatory activity100US 4,996,335 A1991
- Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series74US 5,939,545 ACoCensys, Inc. · 1999
- Anti-inflammatory glucocorticoid compounds for topical ophthalmic use69US 5,420,120 AAlcon Laboratories, Inc. · 1995